MolPort-001-889-834

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

74 Suppliers, 32 USDMF, 19 CEP/COS, 7 JDMF, 13 EU WC, 36 KDMF, 27 NDC API, 41 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

309 Dossiers, 96 FDA Orange Book, 73 Europe, 18 Canada, 14 Australia, 29 South Africa, 79 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 200MG/5ML, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 BASF, 27 Roquette, 22 Kerry, 14 Microlex e.U, 12 Sigachi Industries, 10 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Gangwal Chemicals, 6 SPI Pharma, 6 DFE Pharma, 5 Actylis, 5 Boai NKY Pharmaceuticals Ltd, 5 Nanjing Well Pharmaceutical, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 4 ACG Worldwide, 3 Seppic, 3 Corel Pharma Chem, 3 Lonza Capsugel, 2 Rochem International Inc, 2 DKSH, 2 Seqens, 2 Finar, 2 Nanjing Bold Chemical, 2 Ulanqab Kema New Material, 2 Nomisma Healthcare, 1 Zhejiang Huakang Pharmaceutical, 1 Qualicaps, 1 Kima Chemical, 1 The Dow Chemical Company, 1 Aeon Procare, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Alcedo Pharmachem, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 42 Disintegrants & Superdisintegrants, 36 Direct Compression, 29 Thickeners and Stabilizers, 26 Granulation, 21 Coating Systems & Additives, 21 Solubilizers, 19 Topical, 17 Controlled & Modified Release, 16 Lubricants & Glidants, 15 Film Formers & Plasticizers, 12 Parenteral, 12 Co-Processed Excipients, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 4 Rheology Modifiers, 3 Emulsifying Agents, 1 API Stability Enhancers, 1 Soft Gelatin

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 64 Finished Drug Prices

MARKET PLACE

33 APIs, 23 DOSSIERS // FDF

PATENTS

3 US Patents, 2 US Exclusivities, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 1 USP Standards, 12 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 48 News

Information, Expiry & Status of Health Canada Patents covering MolPort-001-889-834.

MolPort-001-889-834

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

74 Suppliers

32 USDMF

19 CEP/COS

7 JDMF

13 EU WC

36 KDMF

27 NDC API

41 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

309 Dossiers

96 FDA Orange Book

73 Europe

18 Canada

14 Australia

29 South Africa

79 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 200MG/5ML

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 BASF

27 Roquette

22 Kerry

14 Microlex e.U

12 Sigachi Industries

10 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Gangwal Chemicals

6 SPI Pharma

6 DFE Pharma

5 Actylis

5 Boai NKY Pharmaceuticals Ltd

5 Nanjing Well Pharmaceutical

4 Pharmatrans-Sanaq

4 Prachin Chemical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Vasa Pharmachem

4 Ingredion Pharma Solutions

4 ACG Worldwide

3 Seppic

3 Corel Pharma Chem

3 Lonza Capsugel

2 Rochem International Inc

2 DKSH

2 Seqens

2 Finar

2 Nanjing Bold Chemical

2 Ulanqab Kema New Material

2 Nomisma Healthcare

1 Zhejiang Huakang Pharmaceutical

1 Qualicaps

1 Kima Chemical

1 The Dow Chemical Company

1 Aeon Procare

1 Shijiazhuang Huaxu Pharmaceutical

1 Alcedo Pharmachem

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders

42 Disintegrants & Superdisintegrants

36 Direct Compression

CAPSULE;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons